CABAZITAXEL FOR INJECTION
CABAZITAXEL FOR INJECTION
Approved
DIN Number
02487497
Drug Class
Human
Market Date
Dec 18, 2019
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02487497
AIG Number0152936002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD04 CABAZITAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CABAZITAXELActive
Strength: 45 MG / 4.5 ML
Monograph: CABAZITAXEL